When ubiquitination meets phosphorylation: A systems biology perspective of EGFR/MAPK signalling

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages 1-15

  Nguyen, Lan K ^a   Kolch, Walter ^a   Kholodenko, Boris N ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

MAPK signalling; Phosphorylation induced ubiquitination; Quantitative modelling; Ubiquitination; Ubiquitination phosphorylation crosstalk

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ITCH PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MST2 PROTEIN; PROTEIN KINASE; PROTEIN KINASE FYN; RAF PROTEIN; RAS PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG;

APOPTOSIS; ENDOCYTOSIS; HUMAN; MASS SPECTROMETRY; MATHEMATICAL MODEL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; SYSTEMS BIOLOGY; UBIQUITINATION; ANIMAL; METABOLISM; PHOSPHORYLATION;

ANIMALS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; UBIQUITINATION;

EID: 84894460034     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-52     Document Type: Review

References (113)

1. Proteolysis: from the lysosome to ubiquitin and the proteasome. Ciechanover A, Nat Rev Mol Cell Biol 2005 6 79 87 15688069
2. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome. Zaaroor-Regev D, de Bie P, Scheffner M, Noy T, Shemer R, Heled M, Stein I, Pikarsky E, Ciechanover A, Proc Natl Acad Sci USA 2010 107 6788 6793 10.1073/pnas.1003108107 20351251
3. Switches, excitable responses and oscillations in the Ring1B/Bmi1 ubiquitination system. Nguyen LK, Munoz-Garcia J, Maccario H, Ciechanover A, Kolch W, Kholodenko BN, PLoS Comput Biol 2011 7 1002317 10.1371/journal.pcbi. 1002317 22194680
4. Endocytosis and intracellular trafficking of ErbBs. Sorkin A, Goh LK, Exp Cell Res 2009 315 683 696 10.1016/j.yexcr.2008.07.029 19278030
5. Histone ubiquitination: triggering gene activity. Weake VM, Workman JL, Mol Cell 2008 29 653 663 10.1016/j.molcel.2008.02.014 18374642 (Pubitemid 351400924)
6. Histone H2A ubiquitination in transcriptional regulation and DNA damage repair. Zhou W, Wang X, Rosenfeld MG, Int J Biochem Cell Biol 2009 41 12 15 10.1016/j.biocel.2008.09.016 18929679
7. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Ben-Saadon R, Zaaroor D, Ziv T, Ciechanover A, Mol Cell 2006 24 701 711 10.1016/j.molcel.2006. 10.022 17157253 (Pubitemid 44839211)
8. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Hunter T, Mol Cell 2007 28 730 738 10.1016/j.molcel.2007.11.019 18082598 (Pubitemid 350217067)
9. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Magnani M, Crinelli R, Bianchi M, Antonelli A, Curr Drug Targets 2000 1 387 399 10.2174/1389450003349056 11467077
10. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Treier M, Staszewski LM, Bohmann D, Cell 1994 78 787 798 10.1016/S0092-8674(94)90502-9 8087846 (Pubitemid 24294454)
11. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Fuchs SY, Dolan L, Davis RJ, Ronai Z, Oncogene 1996 13 1531 1535 8875991 (Pubitemid 26354201)
12. Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. Witowsky JA, Johnson GL, J Biol Chem 2003 278 1403 1406 10.1074/jbc.C200616200 12456688 (Pubitemid 36801363)
13. Toggle switches, pulses and oscillations are intrinsic properties of the Src activation/deactivation cycle. Kaimachnikov NP, Kholodenko BN, FEBS J 2009 276 4102 4118 10.1111/j.1742-4658.2009.07117.x 19627364
14. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Kholodenko BN, Eur J Biochem 2000 267 1583 1588 10.1046/j.1432-1327.2000.01197.x 10712587 (Pubitemid 30165509)
15. Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Shankaran H, Ippolito DL, Chrisler WB, Resat H, Bollinger N, Opresko LK, Wiley HS, Mol Syst Biol 2009 5 332 19953086
16. FGF induces oscillations of Hes1 expression and Ras/ERK activation. Nakayama K, Satoh T, Igari A, Kageyama R, Nishida E, Curr Biol 2008 18 332 R334 10.1016/j.cub.2008.03.013 18430630 (Pubitemid 351522463)
17. The topology design principles that determine the spatiotemporal dynamics of G-protein cascades. Tsyganov MA, Kolch W, Kholodenko BN, Mol Biosyst 2012 8 730 743 10.1039/c2mb05375f 22218529
18. Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells. Tkachenko E, Sabouri-Ghomi M, Pertz O, Kim C, Gutierrez E, Machacek M, Groisman A, Danuser G, Ginsberg MH, Nat Cell Biol 2011 13 660 667 21572420
19. Coordination of Rho GTPase activities during cell protrusion. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, Nalbant P, Abell A, Johnson GL, Hahn KM, Danuser G, Nature 2009 461 99 103 10.1038/nature08242 19693013
20. Cell-signalling dynamics in time and space. Kholodenko BN, Nat Rev Mol Cell Biol 2006 7 165 176 10.1038/nrm1838 16482094
21. Ubiquitin in trafficking: the network at work. Acconcia F, Sigismund S, Polo S, Exp Cell Res 2009 315 1610 1618 10.1016/j.yexcr.2008.10.014 19007773
22. Nonproteolytic functions of ubiquitin in cell signaling. Chen ZJ, Sun LJ, Mol Cell 2009 33 275 286 10.1016/j.molcel.2009.01.014 19217402
23. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, Lavi S, Iwai K, Reiss Y, Ciechanover A, et al. Mol Cell 1999 4 1029 1040 10.1016/S1097-2765(00)80231-2 10635327 (Pubitemid 30054908)
24. The Cbl interactome and its functions. Schmidt MH, Dikic I, Nat Rev Mol Cell Biol 2005 6 907 918 10.1038/nrm1762 16227975 (Pubitemid 41778710)
25. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC, Science 1999 286 309 312 10.1126/science.286.5438.309 10514377 (Pubitemid 29484697)
26. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Huang F, Sorkin A, Mol Biol Cell 2005 16 1268 1281 10.1091/mbc.E04-09-0832 15635092 (Pubitemid 40349563)
27. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling. Waterman H, Katz M, Rubin C, Shtiegman K, Lavi S, Elson A, Jovin T, Yarden Y, EMBO J 2002 21 303 313 10.1093/emboj/21.3.303 11823423 (Pubitemid 34137292)
28. Grb2 regulates internalisation of EGF receptors through clathrin-coated pits. Jiang X, Huang F, Marusyk A, Sorkin A, Mol Biol Cell 2003 14 858 870 10.1091/mbc.E02-08-0532 12631709 (Pubitemid 36337438)
29. Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl. Dou H, Buetow L, Hock A, Sibbet GJ, Vousden KH, Huang DT, Nat Struct Mol Biol 2012 19 184 192 10.1038/nsmb.2231 22266821
30. Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b. Kobashigawa Y, Tomitaka A, Kumeta H, Noda NN, Yamaguchi M, Inagaki F, Proc Natl Acad Sci USA 2011 108 20579 20584 10.1073/pnas.1110712108 22158902
31. Receptor downregulation and multivesicular-body sorting. Katzmann DJ, Odorizzi G, Emr SD, Nat Rev Mol Cell Biol 2002 3 893 905 10.1038/nrm973 12461556 (Pubitemid 35477368)
32. Molecular mechanisms of coupled monoubiquitination. Woelk T, Oldrini B, Maspero E, Confalonieri S, Cavallaro E, Di Fiore PP, Polo S, Nat Cell Biol 2006 8 1246 1254 10.1038/ncb1484 17013377 (Pubitemid 44660589)
33. Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes. Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, Stenmark H, Nat Cell Biol 2002 4 394 398 10.1038/ncb791 11988743 (Pubitemid 34521037)
34. Endocytosis: the DUB version. Clague MJ, Urbe S, Trends Cell Biol 2006 16 551 559 10.1016/j.tcb.2006.09.002 16996268 (Pubitemid 44636216)
35. Clathrin anchors deubiquitinating enzymes, AMSH and AMSH-like protein, on early endosomes. Nakamura M, Tanaka N, Kitamura N, Komada M, Genes Cells 2006 11 593 606 10.1111/j.1365-2443.2006.00963.x 16716190 (Pubitemid 43744810)
36. Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery. McCullough J, Row PE, Lorenzo O, Doherty M, Beynon R, Clague MJ, Urbe S, Curr Biol 2006 16 160 165 16431367 (Pubitemid 43117430)
37. Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Niendorf S, Oksche A, Kisser A, Lohler J, Prinz M, Schorle H, Feller S, Lewitzky M, Horak I, Knobeloch KP, Mol Cell Biol 2007 27 5029 5039 10.1128/MCB.01566-06 17452457 (Pubitemid 47016150)
38. ERBB2 is a target for USP8-mediated deubiquitination. Meijer IM, van Leeuwen JE, Cell Signal 2011 23 458 467 10.1016/j.cellsig.2010.10.023 21044682
39. The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation. Meijer IM, Kerperien J, Sotoca AM, van Zoelen EJ, van Leeuwen JE, Cell Signal 2013 25 919 930 10.1016/j.cellsig.2013. 01.003 23333852
40. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. Yan J, Roy S, Apolloni A, Lane A, Hancock JF, J Biol Chem 1998 273 24052 24056 10.1074/jbc.273.37.24052 9727023 (Pubitemid 28435747)
41. Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. Voice JK, Klemke RL, Le A, Jackson JH, J Biol Chem 1999 274 17164 17170 10.1074/jbc.274.24.17164 10358073 (Pubitemid 29275179)
42. Ras oncogenes: split personalities. Karnoub AE, Weinberg RA, Nat Rev Mol Cell Biol 2008 9 517 531 10.1038/nrm2438 18568040 (Pubitemid 351881844)
43. Differential modification of Ras proteins by ubiquitination. Jura N, Scotto-Lavino E, Sobczyk A, Bar-Sagi D, Mol Cell 2006 21 679 687 10.1016/j.molcel.2006.02.011 16507365 (Pubitemid 43290734)
44. Ras proteins: different signals from different locations. Hancock JF, Nat Rev Mol Cell Biol 2003 4 373 384 10.1038/nrm1105 12728271 (Pubitemid 36565569)
45. Impairment of ubiquitylation by mutation in Drosophila E1 promotes both cell-autonomous and non-cell-autonomous Ras-ERK activation in vivo. Yan H, Chin ML, Horvath EA, Kane EA, Pfleger CM, J Cell Sci 2009 122 1461 1470 10.1242/jcs.042267 19366732
46. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Horiuchi H, Lippe R, McBride HM, Rubino M, Woodman P, Stenmark H, Rybin V, Wilm M, Ashman K, Mann M, Zerial M, Cell 1997 90 1149 1159 10.1016/S0092-8674(00)80380-3 9323142 (Pubitemid 27408528)
47. Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5. Delprato A, Merithew E, Lambright DG, Cell 2004 118 607 617 10.1016/j.cell.2004.08.009 15339665 (Pubitemid 39179713)
48. Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination. Xu L, Lubkov V, Taylor LJ, Bar-Sagi D, Curr Biol 2010 20 1372 1377 10.1016/j.cub.2010.06.051 20655225
49. Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. Penengo L, Mapelli M, Murachelli AG, Confalonieri S, Magri L, Musacchio A, Di Fiore PP, Polo S, Schneider TR, Cell 2006 124 1183 1195 10.1016/j.cell.2006.02.020 16499958
50. The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. Mattera R, Tsai YC, Weissman AM, Bonifacino JS, J Biol Chem 2006 281 6874 6883 10.1074/jbc.M509939200 16407276 (Pubitemid 43847623)
51. Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM, Bonifacino JS, Hurley JH, Nat Struct Mol Biol 2006 13 264 271 10.1038/nsmb1064 16462746 (Pubitemid 43348513)
52. RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Tam SY, Tsai M, Snouwaert JN, Kalesnikoff J, Scherrer D, Nakae S, Chatterjea D, Bouley DM, Galli SJ, Nat Immunol 2004 5 844 852 10.1038/ni1093 15235600 (Pubitemid 39172978)
53. RabGEF1, a negative regulator of Ras signalling, mast cell activation and skin inflammation. Tam SY, Kalesnikoff J, Nakae S, Tsai M, Galli SJ, Novartis Found Symp 2005 271 115 124 discussion 124-130, 145-151 16605131
54. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Wang Y, Waldron RT, Dhaka A, Patel A, Riley MM, Rozengurt E, Colicelli J, Mol Cell Biol 2002 22 916 926 10.1128/MCB.22.3.916-926.2001 11784866 (Pubitemid 34053068)
55. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1. Han L, Colicelli J, Mol Cell Biol 1995 15 1318 1323 7862125
56. Ubiquitin-binding domains. Hicke L, Schubert HL, Hill CP, Nat Rev Mol Cell Biol 2005 6 610 621 10.1038/nrm1701 16064137 (Pubitemid 41081265)
57. Mapping cellular routes of Ras: a ubiquitin trail. Jura N, Bar-Sagi D, Cell Cycle 2006 5 2744 2747 10.4161/cc.5.23.3532 17172849 (Pubitemid 44901735)
58. Regulating the regulator: post-translational modification of RAS. Ahearn IM, Haigis K, Bar-Sagi D, Philips MR, Nat Rev Mol Cell Biol 2012 13 39 51
59. Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. Sasaki AT, Carracedo A, Locasale JW, Anastasiou D, Takeuchi K, Kahoud ER, Haviv S, Asara JM, Pandolfi PP, Cantley LC, Sci Signal 2011 4 a13 10.1126/scisignal.2001518 21386094
60. Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function. Baker R, Lewis SM, Sasaki AT, Wilkerson EM, Locasale JW, Cantley LC, Kuhlman B, Dohlman HG, Campbell SL, Nat Struct Mol Biol 2013 20 46 52 23178454
61. H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation. Kim SE, Yoon JY, Jeong WJ, Jeon SH, Park Y, Yoon JB, Park YN, Kim H, Choi KY, J Cell Sci 2009 122 842 848 10.1242/jcs.040493 19240121
62. Ubiquitin chains in the ladder of MAPK signaling. Laine A, Ronai Z, Sci STKE 2005 2005 e5 15855411
63. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Warne PH, Viciana PR, Downward J, Nature 1993 364 352 355 10.1038/364352a0 8332195 (Pubitemid 23265279)
64. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Vojtek AB, Hollenberg SM, Cooper JA, Cell 1993 74 205 214 10.1016/0092-8674(93) 90307-C 8334704 (Pubitemid 23219891)
65. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM, Sturgill TW, Science 1992 257 1404 1407 10.1126/science.1326789 1326789
66. Raf-1 activates MAP kinase-kinase. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, Avruch J, Nature 1992 358 417 421 10.1038/358417a0 1322500
67. Raf family kinases: old dogs have learned new tricks. Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, Kolch W, Genes Cancer 2011 2 232 260 10.1177/1947601911407323 21779496
68. Disruption of the Raf-1-Hsp90 molecular complex results in destabilisation of Raf-1 and loss of Raf-1-Ras association. Schulte TW, Blagosklonny MV, Ingui C, Neckers L, J Biol Chem 1995 270 24585 24588 10.1074/jbc.270.41.24585 7592678
69. Geldanamycin-induced destabilisation of Raf-1 involves the proteasome. Schulte TW, An WG, Neckers LM, Biochem Biophys Res Commun 1997 239 655 659 10.1006/bbrc.1997.7527 9367823 (Pubitemid 27504156)
70. CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation. Noble C, Mercer K, Hussain J, Carragher L, Giblett S, Hayward R, Patterson C, Marais R, Pritchard CA, Mol Cell 2008 31 862 872 10.1016/j.molcel.2008.08.026 18922468
71. Dynamic Ubiquitination of the Mitogen-activated Protein Kinase Kinase (MAPKK) Ste7 Determines Mitogen-activated Protein Kinase (MAPK) Specificity. Hurst JH, Dohlman HG, J Biol Chem 2013 288 18660 18671 10.1074/jbc.M113.475707 23645675
72. Regulation of Ste7 ubiquitination by Ste11 phosphorylation and the Skp1-Cullin-F-box complex. Wang Y, Ge Q, Houston D, Thorner J, Errede B, Dohlman HG, J Biol Chem 2003 278 22284 22289 10.1074/jbc.M301272200 12668671 (Pubitemid 36830277)
73. Pheromone-dependent ubiquitination of the mitogen-activated protein kinase kinase Ste7. Wang Y, Dohlman HG, J Biol Chem 2002 277 15766 15772 10.1074/jbc.M111733200 11864977 (Pubitemid 34967852)
74. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T, Mol Cell 2002 9 945 956 10.1016/S1097-2765(02)00519-1 12049732 (Pubitemid 34626666)
75. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ, Nature 1994 372 798 800 7997270
76. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Johnson GL, Lapadat R, Science 2002 298 1911 1912 10.1126/science.1072682 12471242 (Pubitemid 35425238)
77. MEKK1 binds raf-1 and the ERK2 cascade components. Karandikar M, Xu S, Cobb MH, J Biol Chem 2000 275 40120 40127 10.1074/jbc.M005926200 10969079 (Pubitemid 32064638)
78. CHIP-dependent termination of MEKK2 regulates temporal ERK activation required for proper hyperosmotic response. Maruyama T, Kadowaki H, Okamoto N, Nagai A, Naguro I, Matsuzawa A, Shibuya H, Tanaka K, Murata S, Takeda K, et al. EMBO J 2010 29 2501 2514 10.1038/emboj.2010.141 20588253
79. Ubiquitination and endocytosis of plasma membrane proteins: role of Nedd4/Rsp5p family of ubiquitin-protein ligases. Rotin D, Staub O, Haguenauer-Tsapis R, J Membr Biol 2000 176 1 17 10882424 (Pubitemid 30451985)
80. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Fang D, Elly C, Gao B, Fang N, Altman Y, Joazeiro C, Hunter T, Copeland N, Jenkins N, Liu YC, Nat Immunol 2002 3 281 287 10.1038/ni763 11828324 (Pubitemid 34213430)
81. Itch-/- alphabeta and gammadelta T cells independently contribute to autoimmunity in Itchy mice. Parravicini V, Field AC, Tomlinson PD, Basson MA, Zamoyska R, Blood 2008 111 4273 7282 10.1182/blood-2007-10-115667 18256323
82. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Lohr NJ, Molleston JP, Strauss KA, Torres-Martinez W, Sherman EA, Squires RH, Rider NL, Chikwava KR, Cummings OW, Morton DH, Puffenberger EG, Am J Hum Genet 2010 86 447 453 10.1016/j.ajhg.2010.01.028 20170897
83. Itch self-polyubiquitylation occurs through lysine-63 linkages. Scialpi F, Malatesta M, Peschiaroli A, Rossi M, Melino G, Bernassola F, Biochem Pharmacol 2008 76 1515 1521 10.1016/j.bcp.2008.07.028 18718449
84. Activation of the E3 ubiquitin ligase Itch through a phosphorylation- induced conformational change. Gallagher E, Gao M, Liu YC, Karin M, Proc Natl Acad Sci USA 2006 103 1717 1722 10.1073/pnas.0510664103 16446428 (Pubitemid 43228759)
85. Reciprocal regulation of the ubiquitin ligase Itch and the epidermal growth factor receptor signaling. Azakir BA, Angers A, Cell Signal 2009 21 1326 1336 10.1016/j.cellsig.2009.03.020 19341794
86. The ubiquitin ligase Itch mediates the antiapoptotic activity of epidermal growth factor by promoting the ubiquitylation and degradation of the truncated C-terminal portion of Bid. Azakir BA, Desrochers G, Angers A, FEBS J 2010 277 1319 1330 10.1111/j.1742-4658.2010.07562.x 20392206
87. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ, Genes Dev 2000 14 2060 2071 10950869 (Pubitemid 30637355)
88. Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. Breitschopf K, Zeiher AM, Dimmeler S, J Biol Chem 2000 275 21648 21652 10.1074/jbc.M001083200 10801801 (Pubitemid 30481872)
89. Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo. O'Neill E, Kolch W, Cell Cycle 2005 4 365 367 10.4161/cc.4.3.1531 15701972 (Pubitemid 41359716)
90. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. O'Neill E, Rushworth L, Baccarini M, Kolch W, Science 2004 306 2267 2270 10.1126/science.1103233 15618521 (Pubitemid 40024466)
91. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, Baccarini M, Vass JK, Kolch W, O'Neill E, Mol Cell 2007 27 962 975 10.1016/j.molcel.2007.08.008 17889669 (Pubitemid 47495894)
92. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Ho KC, Zhou Z, She YM, Chun A, Cyr TD, Yang X, Proc Natl Acad Sci USA 2011 108 4870 4875 10.1073/pnas.1101273108 21383157
93. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Levy D, Adamovich Y, Reuven N, Shaul Y, Cell Death Differ 2007 14 743 751 10.1038/sj.cdd.4402063 17110958 (Pubitemid 46444512)
94. Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Yang C, Zhou W, Jeon MS, Demydenko D, Harada Y, Zhou H, Liu YC, Mol Cell 2006 21 135 141 10.1016/j.molcel.2005.11.014 16387660 (Pubitemid 43017855)
95. Modelling the dynamics of the yeast pheromone pathway. Kofahl B, Klipp E, Yeast 2004 21 831 850 10.1002/yea.1122 15300679 (Pubitemid 39162579)
96. Scaffold number in yeast signaling system sets tradeoff between system output and dynamic range. Thomson TM, Benjamin KR, Bush A, Love T, Pincus D, Resnekov O, Yu RC, Gordon A, Colman-Lerner A, Endy D, Brent R, Proc Natl Acad Sci USA 2011 108 20265 20270 10.1073/pnas.1004042108 22114196
97. A modelling approach to quantify dynamic crosstalk between the pheromone and the starvation pathway in baker's yeast. Schaber J, Kofahl B, Kowald A, Klipp E, FEBS J 2006 273 3520 3533 10.1111/j.1742-4658.2006.05359.x 16884493 (Pubitemid 44086952)
98. MAPK-mediated bimodal gene expression and adaptive gradient sensing in yeast. Paliwal S, Iglesias PA, Campbell K, Hilioti Z, Groisman A, Levchenko A, Nature 2007 446 46 51 10.1038/nature05561 17310144 (Pubitemid 46348042)
99. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE, Proc Natl Acad Sci USA 2004 101 9085 9090 10.1073/pnas.0402770101 15150404 (Pubitemid 38781615)
100. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI, EMBO J 2004 23 2116 2125 10.1038/sj.emboj.7600217 15103331 (Pubitemid 38737738)
101. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C, EMBO J 2002 21 4037 4048 10.1093/emboj/cdf406 12145204 (Pubitemid 34857436)
102. Ubiquitin-mediated degradation of Rpn4 is controlled by a phosphorylation-dependent ubiquitylation signal. Ju D, Xu H, Wang X, Xie Y, Biochim Biophys Acta 2007 1773 1672 1680 10.1016/j.bbamcr.2007.04.012 17532487 (Pubitemid 350018908)
103. Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer. Hu H, Goltsov A, Bown JL, Sims AH, Langdon SP, Harrison DJ, Faratian D, Cell Signal 2013 25 26 32 10.1016/j.cellsig.2012.09.014 23000339
104. Why cytoplasmic signalling proteins should be recruited to cell membranes. Kholodenko BN, Hoek JB, Westerhoff HV, Trends Cell Biol 2000 10 173 178 10.1016/S0962-8924(00)01741-4 10754559 (Pubitemid 30193260)
105. Cooperative activation of PI3K by Ras and Rho family small GTPases. Yang HW, Shin MG, Lee S, Kim JR, Park WS, Cho KH, Meyer T, Do Heo W, Mol Cell 2012 47 281 290 10.1016/j.molcel.2012.05.007 22683270
106. Decoding signalling networks by mass spectrometry-based proteomics. Choudhary C, Mann M, Nat Rev Mol Cell Biol 2010 11 427 439 10.1038/nrm2900 20461098
107. Systematic and quantitative assessment of the ubiquitin-modified proteome. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, et al. Mol Cell 2011 44 325 340 10.1016/j.molcel.2011.08.025 21906983
108. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al. Sci Signal 2010 3 a3 10.1126/scisignal.2000475 20068231
109. Large-scale proteomics analysis of the human kinome. Oppermann FS, Gnad F, Olsen JV, Hornberger R, Greff Z, Keri G, Mann M, Daub H, Mol Cell Proteomics 2009 8 1751 1764 10.1074/mcp.M800588-MCP200 19369195
110. Characterizing the connectivity of poly-ubiquitin chains by selected reaction monitoring mass spectrometry. Mirzaei H, Rogers RS, Grimes B, Eng J, Aderem A, Aebersold R, Mol Biosyst 2010 6 2004 2014 10.1039/c005242f 20694217
111. Functional and quantitative proteomics using SILAC. Mann M, Nat Rev Mol Cell Biol 2006 7 952 958 10.1038/nrm2067 17139335 (Pubitemid 44871421)
112. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C, Mol Cell Proteomics 2011 10 111 M013284 21986994
113. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Swaney DL, Beltrao P, Starita L, Guo A, Rush J, Fields S, Krogan NJ, Villen J, Nat Methods 2013 10 676 682 10.1038/nmeth.2519 23749301